Harvesting fetal cells from the maternal circulation

Fetal and Maternal Medicine Review

Volumn 16, Issue 2, 2005, Pages 151-177

  McEwan, Alec ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD71 ANTIGEN; EDETIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA GLOBIN; GLYCOPHORIN A; HEPARIN; THROMBOSPONDIN;

ANEUPLOIDY; ANTIGEN EXPRESSION; BETA THALASSEMIA; DIAGNOSTIC ACCURACY; DNA SEQUENCE; DOWN SYNDROME; DUCHENNE MUSCULAR DYSTROPHY; ERYTHROCYTE; FETUS CELL; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HIGH RISK PREGNANCY; HUMAN; LEUKOCYTE COUNT; MATERNAL BLOOD; MICROMANIPULATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SICKLE CELL ANEMIA; SURGICAL TECHNIQUE; TROPHOBLAST;

EID: 24744456674     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539505001488     Document Type: Review

References (148)

1. Schmorl G. Pathologiisch-Anatomische Untersuchungen uber Puubleraleklampsie. 1893 Leipzig: Vogel.
2. Walknowska J, Conte FA, Grumback MM. Practical and theoretical implications of fetal/maternal lymphocyte transfer. Lancet 1969; 1: 1119-122.
3. Herzenberg LA, Bianchi DW, Schröder J, Cann HM, Iverson GM. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proct Natl Acad Sci USA 1979; 76: 1453-455.
4. Mackenzie IZ, Bowell P, Gregory H, Pratt G, Guest C, Entwistle CC. Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study. BJOG 1999; 106: 492-97.
5. Ganshirt-Ahlert D, Burschyk M, Garritsen HSP, Helmer L, Miny P, Horst J, Hermann PG, Schneider PG, Holzgreve W. Magnetic cell sorting and the transferrin receptor as potential means of prenatal diagnosis from maternal blood. Am J Obstet Gynecol 1992; 166: 1350-355.
6. Durrant LG, Martin WL, McDowall KM, Liu DTY. Isolation of fetal trophoblasts and nucleated erythrocytes from the peripheral blood of pregnant women for prenatal diagnosis of fetal aneuploidies. Early Hum Dev 1996; 47: 79-83.
7. de Graaf IM, Jakobs ME, Leschot NJ, Ravkin I, Goldbard S, Hoovers JMN. Enrichment, identification and analysis of fetal cells from maternal blood: Evaluation of a prenatal diagnosis system. Prenat Diagn 1999; 19: 648-52.
8. Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, Evans MI, et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. Prenat Diagn 2002; 22: 609-615.
9. Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH. Investigation of maternal blood enriched for fetal cells: Role in screening and diagnosis of fetal trisomies. Am J Med Genet 1999; 85: 66-75
10. de Alba MR, Palomino P, Jurado A, Sanz R, Ibanez MA, Fernandez-Moya J et al. Prenatal diagnosis on fetal cells obtained from maternal peripheral blood: report of 66 cases. Prenat Diagn 1999; 19: 934-40.
11. Lim TH, Tan A, Goh VHH. Enrichment of fetal trophoblasts and nucleated erythrocytes from maternal blood by an immunomagnetic colloid system. Hum Genet 1999; 104: 399-404.
12. Sekizawa A, Watanabe A, Kimura T, Saito H, Yanaihara T, Sato T. Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternalblood. Obstet Gynecol 1996; 87: 501-505.
13. Bayrak-Toydemir P, Pergament E, Fiddler M. Are fetal cells in maternal plasma really there? We think they are. J Hum Genet 2003; 48: 665-67.
14. Mavrou A, Kolialexi A, Antsaklis A, Korantzis A, Metaxotou C. Identification of fetal nucleated red blood cells in the maternal circulation during pregnancy using anti-hemoglobin-epsilon antibody. Fetal Diagn Ther 2003; 18: 309-13.
15. Slunga-Tallberg A, El Rifai W, Keinanen M, Ylinen K, Kurki T, Klinger K et al. Maternal origin of nucleated erythrocytes in peripheral blood of pregnant women. Hum Genet 1995; 96: 53-57.
16. Sohda S, Arinami T, Hamada H, Nakauchi H, Hamaguchi H, Kubo T. The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis. Prenat Diagn 1997; 17: 743-52.
17. Troeger C, Zhong XY, Burgemeister R, Minderer S, Tercanli S, Holzgreve W, Hahn S. Approximately half of the erythrobalsts in maternal blood are of fetal origin. Mol Hum Reprod 1999; 5: 1162-165.
18. Brosens I, Robertson WB and Dixon HG. The role of the spiral arteries in the pathogenesis of pre-eclampsia. Obstetric Gynaecol Annals 1972; 1: 177-91.
19. Mueller UW, Hawes CS, Jones WR. Identification of extravillous trophoblast cells in human decidua using an apparently unique murine monoclonal antibody to trophoblast. Histochem J 1987; 19: 288-96.
20. van Wijk IJ, van Vugt JMG, Konst AAM, Mulders MAM, Florijn WJ, Oudejans CBM. Identification of HASH2-positive extravillous trophoblasts cells in the peripheral blood of pregnant women. Trophoblast Res 1998; 11: 23-33.
21. Attwood HD, Park WW. Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonwealth 1958; 68: 611-17.
22. Hawes CS, Suskin HA, Petrpoulos A, Latham S, Mueller UW. A morphologic study of trophoblast isolated from peripheral blood of pregnant women. Am J Obstet Gynecol 1994; 170: 1297-300.
23. Vona G, Beroud C, Benachi A, Quenette A, Bonnefont JP, Romana S et al. Enrichment, Immunomorphological, and genetic characterisation of fetal cells circulating in maternal blood. Am J Pathol 2002; 160: 51-58.
24. Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol 1991; 98: 973-79.
25. Mueller UW, Hawes CS, Wright AE, Petropoulos A, DeBoni E, Firgaira FA et al. Isolation of fetal trophoblast cells from peripheral blood of pregnant women. Lancet 1990; 336: 197-200.
26. van Wijk IJ, van Vugt JMG, Mulders MAM, Konst AAM, Weima SM, Oudejans CBM. Enrichment of fetal trophoblast cells from the maternal peripheral blood followed by detection of fetal deoxyribonucleic acid with a nested X/Y polymerase chain reaction. Am J Obstet Gynecol 1996; 174: 871-76.
27. Sbracia M, Scarpellini F, Lalwani S, Grasso JA, Scarpellini L. Possible use of an unusual HLA antigen to select trophoblast cells from the maternal circulation to perform early prenatal diagnosis. Ann NY Acad Sci USA 1994; 731: 170-74.
28. Lim TH, Tan A, Goh VHH. Relationship between gestational age and frequency of fetal trophoblasts and nucleated erythrocytes in maternal peripheralblood. Prenat Diagn 2001; 21: 14-21.
29. Taniguchi R, Koizumi T, Das H, Chakraborty S, Sugimoto T, Hasegawa K et al. Trophoblastic cells expressing human chorionic gonadotrophin genes in peripheral blood of patients with trophoblastic disease. Life Sci 2001; 66: 1593-601.
30. Oudejans CBM, Tjoa ML, Westerman BA, Mulders MAM, van Wijk IJ, van Vugt JMG. Circulating trophoblasts in maternalblood. Prenat Diagn 2003; 23: 111-16.
31. Kalousek DK, Vekemans M. Confined placental mosaicism. J Med Genet 1996; 33: 529-33.
32. Farra C, Giudicelli B, Pellissier MC, Phillip N, Piquet C. Fetoplacental chromosomal discrepancy. Prenat Diagn 2000; 20: 190-93.
33. Pittalis MC, Dalpra L, Torricelli F, Rizzo N, Nocera G, Cariati E et al. The predictive value of cytogenetic diagnosis after CVS based on 4860 cases with both direct and culture methods. Prenat Diagn 1994; 14: 267-78.
34. Sargent IL, Choo YS, Redman CWG. Isolating and analysing fetal leukocytes in maternal blood. Ann NY Acad Sci USA 1994; 731: 147-53.
35. Schröder J, Tilikainen A, de la Chapelle A. Fetal leukocytes in maternal circulation after delivery. Transplantation 1974; 17: 346-60.
36. Ciaranfi A, Curchod A, Odartchenko N. Postpartum survival of fetal lymphocytes in the maternalblood. Schweizerische Medizinische Wochenschrift 1977; 107: 134-38.
37. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria M. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996; 93: 705-708.
38. Little M, Langlois S, Wilson RD, Lansdorp PM. Frequency of fetal cells in sorted subpopulations of nucleated erythroid and CD34+ haematopoietic progenitor cells from maternal peripheralblood. Blood 1997; 89: 2347-358.
39. Campagnoli C, Fisk NM, Overton T, Bennett P, Watts T, Roberts IAG. Circulating haematopoietic progenitor cells in first trimester fetal blood. Blood 2000; 95: 1967-972.
40. Ganshirt-Ahlert D, Borjesson-Stoll R, Burschk M, Dohr A, Garritsen HSP, Helmer E et al. Detection of fetal trisomies 21 and 18 from maternal blood using triple gradient and magnetic cell sorting. Am J Reprod Immunol 1993; 30: 194-201.
41. Simpson JL, Lewis DE, Bischoff FZ, Elias S. Isolating fetal nucleated red blood cells from maternal blood: the Baylor experience-1995. Prenat Diagn 1995; 15: 907-12.
42. Jansen MWJC, Brandenburg H, Wildschut HIJ, Martens ACM, Hagenaars AM, Wladimiroff JW et al. The effect of chorionic villus sampling on the number of fetal cells isolated from maternal blood and on maternal serum alpha-fetoprotein levels. Prenat Diagn 1997; 17: 953-59.
43. Bischoff FZ, Lewis DE, Nguyen DD, Murrell S, Schober W, Scott J et al. Prenatal diagnosis with use of fetal cells isolated from maternal blood: Five-color fluorescence in situ hybridisation analysis on flow-sorted cells for chromosomes X, Y, 13, 18 and 21. Am J Obstet Gynecol 1998; 179: 203-209.
44. de Alba MR, Palomino P, Gonzalez-Gonzalez C, Lorda-Sanchez I, Ibanez MA, Sanz R et al. Prenatal diagnosis on fetal cells from maternal blood: practical comparative evaluation of the first and second trimesters. Prenat Diagn 2001; 21: 165-70.
45. Martel-Petit V, Petit C, Marchand M, Fleurentin A, Fontaine B, Miton A et al. Use of the Kleihauer test to detect fetal erythroblasts in the maternal circulation. Prenat Diagn 2001; 21: 106-11.
46. Kitagawa M, Sugiura K, Omi H, Akiyama Y, Kanayama K, Shinya M et al. New technique using galactose-specific lectin for isolation of fetal cells from maternal blood. Prenat Diagn 2002; 22: 17-21.
47. Simpson JL, Elias S. Genetics in Obstetrics and Gynaecology. Third Edition. Saunders 2003; 445.
48. Troeger C, Holzgreve W, Hahn S. A comparison of different density gradients and antibodies for enrichment of fetal erythroblasts by MACS. Prenat Diagn 1999; 19: 521-26.
49. Wachtel SS, Sammons D, Twitty G, Utermohlen J, Tolley E, Phillips O et al. Charge flow separation: quantification of nucleated red blood cells in maternal blood during pregnancy. Prenat Diagn 1998; 18: 455-63.
50. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR Quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997; 61: 822-29.
51. Ariga H, Ohto H, Butsch MP, Imamura S, Watson R, Reed W et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for non-invasive diagnosis. Transfusion 2001; 41: 1524-530.
52. Krabchi K, Gros-Louis F, Yan J, Bronsard M, Masse J, Forest JC et al. Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 2001; 60: 145-50.
53. Shulman LP, Phillips OP, Tolley E, Sammons D, Wachtel SS. Frequency of nucleated red blood cells in maternal blood during different gestational ages. Hum Genet 1998; 103: 723-26.
54. Zhong XY, Burk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 2000; 20: 795-98.
55. Prieto B, Candenas M, Venta R, Ladenson JH, Alvarez FV. Isolation of fetal nucleated red blood cells from maternal blood in normal and aneuploid pregnancies. Clin Chem Lab Med 2002; 40: 667-72.
56. Sebire NJ, Fowler D, Roberts L, Mahmood S, Nicolaides KH. Trophoblast proliferation is increased in chorionic villi from pregnancies with fetal trisomy 18. Placenta 2000; 21: 584-86.
57. Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH. Distribution of fetal erythroblasts in maternal blood after chorionic villus sampling. BJOG 2003; 110: 33-38.
58. Holzgreve W, Ghezzi F, Di Naro E, Ganshirt D, Maymon E, Hahn S. Disturbed feto-maternal traffic in preeclampsia. Obstet Gynecol 1998; 91: 669-72.
59. Jansen MWJC, Korver-Hakkennes K, van Leenen D, Visser W, Veld PA, de Groot CJM et al. Significantly higher numbers of fetal cells in the maternal circulation of women with pre-eclampsia. Prenat Diagn 2001; 21: 1022-1026.
60. Al-Mufti R, Hambley H, Albaiges G, Lees C, Nicolaides KH. Increased fetal erythroblasts in women who subsequently develop pre-eclampsia. Hum Reprod 2000; 15: 1624-628.
61. Holgreve W, Li JJ, Steinborn A, Kulz T, Sohn C, Hodel M, Hahn S. Elevation in erythroblast count in maternal blood before the onset of preeclampsia. Am J Obstet Gynecol 2001; 184: 165-68.
62. Al-Mufti R, Lees C, Albaiges G, Hambley H, Nicolaides KH. Fetal cells in maternal blood of pregnancies with severe fetal growth restriction. Hum Reprod 2000; 15: 218-21.
63. Simchen MJ, Brkai G, Lusky A, Guetta E. Fetal haemoglobin-expressing nucleated red blood cell frequencies in pregnancies with intrauterine growth restriction. Prenat Diagn 2001; 21: 31-35.
64. Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH. Distribution of fetal erythroblasts enriched from maternal blood in multifetal pregnancies. Hum Reprod 2003; 18: 1933-936.
65. Jansen MWJC, Korver-Hakkennes K, van Leenen D, Visser W, Veld PA, de Groot CJ et al. How useful is the in vitro expansion of fetal CD34+ progenitor cells from maternal blood samples for diagnostic purposes? Prenat Diagn 2000; 20: 725-731.
66. Valerio D, Vincenzo A, Antonucci FR, Aiello R. Characterization of fetal haematopoietic progenitors circulating in maternal blood of seven aneuploid pregnancies. Prenat Diagn 1997; 17: 1159-169.
67. Tutschek B, Reinhard J, Kogler G, Wernet P, Niederacher D. Clonal culture of fetal cells from maternal blood. Lancet 2000; 356: 1736-737.
68. Guetta E, Gordon D, Simchen MJ, Goldman B, Barkai G. Haematopoietic progenitor cells as targets for non-invasive prenatal diagnosis: detection of fetal CD34+ cells and assessment of post-delivery persistence in the maternal circulation. Blood cells Mol Dis 2003; 30: 13-21.
69. Campagnoli C, Roberts IAG, Kumar S, Choolani M, Bennett PR, Letsky E, Fisk NM. Expandability of haemopoietic progenitors in first trimester fetal and maternal blood: implications for non-invasive prenatal diagnosis. Prenat Diagn 2002; 22: 463-69.
70. Chen H, Griffin DK, Jestice K, Hackett G, Cooper J, Ferguson-Smith MA. Evaluating the culture of fetal erythroblasts from maternal blood for non-invasive prenatal diagnosis. Prenat Diagn 1998; 18: 883-92.
71. Bohmer RM, Campbell TA, Bianchi DW. Selectively increased growth of fetal haemoglobin-expressing adult erythroid progenitors after brief treatment of early progenitors with transforming growth factor beta. Blood 2000; 95: 2967-974.
72. Sekizawa A, Farina A, Zhen DK, Wang JY, Falco VM, Elmes RS et al. Improvement of fetal cell recovery from maternal blood: suitable density gradient for FACS separation. Fetal Diagn Ther 1999; 14: 229-33.
73. Samura O, Sekizawa A, Zhen DK, Falco VM, Bianchi DW. Comparison of fetal cell recovery from maternal blood using a high density gradient for the initial separation step: 1.090 versus 1.119 g/ml. Prenat Diagn 2000; 20: 281-86.
74. Voullaire L, Ioannou P, Nouri S, Williamson R. Fetal nucleated red blood cells from CVS washings: an aid to development of first trimester non-invasive prenatal diagnosis. Prenat Diagn 2001; 21: 827-34.
75. van Wijk IJ, de Hoon AC, Jurhawan R, Tjoa ML, Griffioen S, Mulders MA et al. Detection of apoptotic fetal cells in plasma of pregnant women. Clin Chem 2000; 46: 729-31.
76. Sekizawa A, Samura O, Zhen D, Falco V, Farina A, Bianchi DW. Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 2000; 20: 886-89.
77. Kolialexi A, Tsangaris GT, Antsaklis A, Mavrou A. Fetal cells in maternal plasma are found in late apoptosis. Prenat Diagn 2004; 24: 719-21.
78. Karl PI, Alpy KL, Fisher SE. Serial enzymatic digestion method for isolation of human placental trophoblasts. Placenta 1992; 13: 385-87.
79. Bonnefont JP, Benachi A, Munnich A, Dumez Y, Lacour B, Paterlini-Brechot P. Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells. Lancet 2003; 361: 1013-1014.
80. Price JO, Elias S, Wachtel SS, Klinger K, Dockter M, Tharapel A et al. Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry. Am J Obstet Gynecol 1991; 165: 1731-737.
81. DeMaria MA, Zheng YL, Zhen D, Weinschenk NM, Vadnais TJ, Bianchi DW. Improved fetal nucleated erythrocyte sorting purity using intracellular antifetal haemoglobin and Hoechst 33342. Cytometry 1996; 25: 37-45.
82. Choolani M, O'Donnell H, Campagnoli C, Kumar S, Roberts I, Bennett PR et al. Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosome fluorescence in situ hybridisation. Blood 2001; 98: 554-57.
83. Durrant L, McDowall K, Holmes R and Liu D. Non-invasive prenatal diagnosis by isolation of both trophoblasts and fetal nucleated red blood cells from the peripheral blood of pregnant women. Br J Obstet Gynaecol 1996; 103: 219-22.
84. Hviid TVF, Sorensen S, Morling N. Detection of fetal-specific DNA after enrichment for trophoblasts using the monoclonal antibody LK26 in model systems but failure to demonstrate fetal DNA in maternal peripheral blood. Prenat Diagn 1999; 19: 271-78.
85. Covone AE, Mutton D, Johnson PM, Adinolfi M. Trophoblast cells in peripheral blood from pregnant women. Lancet 1984; 2: 841-43.
86. Covone AE, Kozma ER, Johnson PM, Latt SA, Adinolfi M. Analysis of peripheral maternal blood samples for the presence of placental-derived cells using Y-specific probes and McAb H315. Prenat Diagn 1988; 8: 591-607.
87. Mueller UW, Hawes CS, Jones WR. Cell surface antigens of human trophoblast: definition of an apparently unique system with a monoclonal antibody. Immunology 1986; 59: 135-38.
88. Johansen M, Knight M, Maher EJ, Smith K, Sargent IL. An investigation of methods for enriching trophoblast from maternal blood. Prenat Diagn 1995; 15: 921-31.
89. Martin B, Bruce J, Smith N, Liu D, Durrant L. A magnetic colloid system for isolation of rare cells from blood for FISH analysis. Prenat Diagn 1997; 17: 1059-1066.
90. Marquez-Do DA, Martinez DI, Dang D, Home C, Lewis D, Simpson JL. Intact fetal cell isolation from maternal blood: improved isolation using a simple whole blood progenitor cell enrichment approach (RosetteSep). Clin Genet 2003; 63: 483-89.
91. Wachtel SS, Sammons D, Manley M, Wachtel G, Twitty G, Utermohlen J et al. Fetal cells in maternal blood: recovery by charge flow separation. Hum Genet 1996; 98: 162-66.
92. Zhao XX, Ozaki Y, Suzumori N, Sato T, Suzumori K. An examination of different fetal specific antibodies and magnetic activated cell sorting for the enrichment of fetal erythroblasts from maternal blood. Congenit Anom Kyoto 2002; 42: 175-80.
93. van Wijk IJ, Griffioen S, Tjoa ML, Mulders M, van Vugt JMG, Loke YW et al. HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy. Am J Obs Gynecol 2001; 184: 991-97.
94. Hennerbichler S, Kroisel PM, Zierler H, Pertl B, Wintersteiger R, Dohr G et al. Fetal nucleated red blood cells in peripheral blood of pregnant women: detection and determination of location on a slide using laser scanning cytometry. Prenat Diagn 2003; 23: 710-15.
95. Pembrey ME, Weatherall DJ, Clegg JB. Maternal synthesis of haemoglobin F in pregnancy. Lancet 1973; 1: 1350-354.
96. Maniatis T, Melon P, Parker V, Proudfoot N, Seed B. In: Bird SJ, Bloom FE (eds.). Molecular Genetics of Neuroscience New York: Raven Press; 1982: 7-101.
97. Bayrak-Toydemir P, Pergament E, Fiddler M. Applying a test system for discriminating fetal from maternal cells. Prenat Diag 2003; 23: 619-24.
98. Cha D, Hogan B, Bohmer R, Bianchi DW, Johnson KL. A simple and sensitive erythroblast scoring system to identify fetal cells in maternal blood. Prenat Diagn 2003; 23: 68-73.
99. Larsen RD, Schonau A, Thisted M, Petersen HP, Lohse J, Christensen B et al. Detection of gamma-globin mRNA in fetal nucleated red blood cells by PNA fluorescence in situ hybridisation. Prenat Diagn 2003; 23: 52-59.
100. Høgh AM, Hviid TV, Christensen B, Sorensen S, Larsen RD, Smidt-Jensen S et al. zeta-, epsilon-, and gamma globin mRNA in blood samples and CD71(+) cell fractions from fetuses and from pregnant and nonpregnant women, with special attention to identification of fetal erythroblasts. Clin Chem 2001; 47: 645-53.
101. Boye K, Hougaard DM, Ebbesen P, Vuust J, Christiansen M. Novel feto-specific mRNA species suitable for identification of fetal cells from the maternal circulation. Prenat Diagn 2001; 21: 806-12.
102. Schueler PA, Yamannishi DT, Pearson J, Lee Y, Wu X, Hashima S et al. Inconsistency of fetal trophoblast cells in first trimester maternal peripheral blood prevents non-invasive fetal testing using this cell target. Placenta 2001; 22: 702-15.
103. Truong K, Gibaud A, Dupont JM, Guilly MN, Soussaline F, Dutrillaux B et al. Rapid prenatal diagnosis of Down syndrome using quantitative fluorescence in situ hybridisation on interphase nuclei. Prenat Diagn 2003; 23: 146-51.
104. Castleman KR. Strategies for automated fetal cell screening. Hum Reprod Update 2002; 8: 509-21.
105. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000; 46: 301-302.
106. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis from maternal plasma in the case of fetal achondroplasia. Lancet 2000; 356: 1170.
107. Eiben B, Trawicki W, Hammans W, Goebel R, Epllen JT. A prospective comparative study on fluorescence in situ hybridisation (FISH) of uncultured amniocytes and standard karyotypic analysis. Prenat Diagn 1998; 18: 901-906.
108. Lewin P, Kleinfinger P, Bazin A, Mossafa H, Szpiro-Tapia S. Defining the efficiency of fluorescence in situ hybridisation on uncultured amniocytes on a retrospective cohort of 27407 prenatal diagnoses. Prenat Diagn 2000; 20: 1-6.
109. Brombacher V, Kiefer V, Troeger C, Vial Y, Minderer S, Holzgreve W et al. Choice of anticoagulant can influence the analysis using fluorescence in situ hybridisation of fetal cells enriched from maternal blood. Prenat Diagn 2000; 20: 257-59.
110. Grimshaw GM, Szczepura A, Hulten M, MacDonald F, Nevin NC, Sutton F et al. Evaluation of molecular tests for prenatal diagnosis of chromosomal abnormalities. Health Technol Assess 2003; 7: 1-110.
111. Murrell-Bussell S, Nguyen D, Schober WD, Scott J, Simpson JL, Elias S et al. Optimised fixation and storage conditions for FISH analysis of single-cell suspensions. J Histochem Cytochem 1998; 46: 971-73.
112. Kuo PL, Guo HR. Magnetic-activated cell sorting (MACS) significantly decreases the hybridisation efficiency of fluorescence in situ hybridisation (FISH). Prenat Diagn 2001; 21: 359-61.
113. Jakobs ME, van Lith JMM, de Graaf IM, Knegt AC, Hoovers JMN. Genetic analysis of fetal nucleated red blood cells from CVS washings. Prenat Diagn 2000; 20: 832-34.
114. Zhang L, Cui X, Schmitt K, Hubert R, Navidi W, Arnheim N. Whole genome amplification from a single cell - implications for genetic analysis. Proc Natl Acad Sci USA 1992; 89: 5847-851.
115. Harper JC, Wells D. Recent advances and future developments in PGD. Prenat Diagn 1999; 19: 1193-199.
116. Findlay I, Urquhart A, Quirke P, Sulivan K, Rutherford A, Lilford R. Simultaneous DNA 'fingerprinting', diagnosis of sex and single-gene defect status from single cells. Mol Hum Reprod 1995; 10: 1005-1013.
117. Sekizawa A, Taguchi A, Watanabe A, Kimura T, Saito H, Yanaihara T et al. Analysis of HLA-DQ α sequences for prenatal diagnosis in single fetal cells from maternal blood. Hum Genet 1998; 102: 393-96.
118. Takabayashi H, Kuwabara S, Ukita T, Ikawa K, Yamafuji K, Igarashi T. Development of non-invasive fetal DNA diagnosis from maternal blood. Prenat Diagn 1995; 15: 74-77.
119. Sekizawa A, Kimura T, Sasaki M, Nakamura S, Kobayashi R, Sato T. Prenatal diagnosis of Duchenne muscular dystrophy using a single fetal nucleated erythrocyte in maternal blood. Neurology 1996; 46: 1350-353.
120. Cheung M, Goldberg JD, Wai Kan Y. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 1996; 14: 264-68.
121. Parano E, Falcidia E, Grillo A, Pavone P, Cutuli N, Takabayashi H et al. Noninvasive prenatal diagnosis of chromosomal aneuploidies by isolation and analysis of fetal cells from maternal blood. Am J Hum Genet 2001; 101: 262-67.
122. Jackson L. Fetal cells and DNA in maternal blood. Prenat Diagn 2003; 23: 837-46.
123. Hviid TV. In-cell PCR method for specific genotyping of genomic DNA from one individual in a mixture of cells from two individuals: a model study with specific relevance to prenatal diagnosis based on fetal cells in maternal blood. Clin Chem 2002; 48: 2115-123.
124. Adinolfi M, Davies A, Sharif S. Detection of trisomy 18 and Y-derived sequences in fetal nucleated cells obtained by transcervical flushing. Lancet 1993; 342: 403-404.
125. Adinolfi M, Sherlock J, Kemp T. Prenatal detection of fetal RhD DNA sequences in transcervical samples. Lancet 1995; 345: 318-19.
126. Adolfini M, Sherlock J, Tutschek B, Halder A, Delhanty J, Rodeck C. Detection of fetal cells in transcervical samples and prenatal diagnosis of chromosomal abnormalities. Prenat Diagn 1995; 15: 943-49.
127. Briggs J, Miller D, Bulmer J, Griffith-Jones M, Rame V, Lilford R. Non-syncytial sources of fetal DNA in transcervically recovered cell population. Mol Hum Reprod 1995; 10: 749-54.
128. Overton TG, Fisk NM, Bennett PR. Transcervical first trimester sampling: a viable route for prenatal diagnosis? Contemp Rev Obstet Gynaecol 1996; 8: 69-74.
129. Falcinelli C, Battafarano S, Neri C, Mazza V, Ranzi A, Forabosco A. Analysis of fetal sex in TCC sample DNA: a contribution to the validation of this approach. Prenat Diagn 1998; 18: 1109-116.
130. Chang S, Lin S, Chu K, His B. Minimally invasive early prenatal diagnosis using fluorescence in situ hybridisation on samples from uterine lavage. Prenat Diagn 1997; 17: 1019-1025.
131. Kingdom J, Sherlock J, Rodeck C, Adinolfi M. Detection of trophoblast cells in transcervical samples collected by lavage or cytobrush. Obstet Gynecol 1995; 86: 283-88.
132. Bussani C, Cioni R, Scarselli B, Barciulli F, Bucciantini S, Simi P et al. Strategies for the isolation and detection of fetal cells in transcervical samples. Prenat Diagn 2002; 22: 1098-101.
133. Cioni R, Bussani C, Scarselli B, Bucciantini S, Barciulli F, Scarselli G. Fetal cells in cervical mucus in the first trimester of pregnancy. Prenat Diagn 2003; 23: 168-171.
134. Bulmer JN, Cioni R, Bussani C, Cirigliano V, Sole F, Costa C et al. HLA-G positive trophoblastic cells in transcervical samples and their isolation and analysis by laser microdissection and QF-PCR. Prenat Diagn 2003; 23: 34-39.
135. Lo YM, Patel P, Wainscoat JS, Sampietro M, Gillmer MDG, Fleming KA. Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet 1989; 2: 1363-365.
136. Lo YMD, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Cheng AM, Hjelm NM. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for non-invasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-75.
137. Ng EK, Tsui NBY, Lau TK, Leung TN, Chiu RW, Panesar NS et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003; 100: 4748-753.
138. Costa J-M, Benachi A, Gautier E, Jouannic J-M, Ernault P, Dumez Y. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 2001; 21: 1070-1074.
139. Costa J-M, Giovangrandi Y, Ernault P. Fetal RhD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 2002; 119: 255-60.
140. Li Y, Holzgreve W, Page-Christiaens GCML, Gille JJP, Hahn S. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma - case report. Prenat Diagn 2004; 24: 896-98.
141. Pertl B, Bianchi DW. Fetal DNA in maternal plasma: emerging clinical applications. Obstet Gynecol 2001; 3: 483-90.
142. Wald NJ, Hackshaw AK. Advances in antenatal screening for Down Syndrome. Ballieres Clin Obstet Gynaecol 2000; 14: 563-80.
143. Muller F, Benattar C, Audibert F, Roussel N, Dreux S, Cuckle H. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical makers. Prenat Diagn 2003; 23: 833-36.
144. Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β-HCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003; 23: 306-10.
145. Viora E, Masturzo B, Errante G, Sciarrone A, Bastonero S, Campogrande M. Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses. Prenat Diagn 2003; 23: 784-87.
146. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003; 7: 1-77.
147. Mansfield ES. Diagnosis of Down's syndrome and other aneuploidies using quantitative polymerase chain reaction and small tandem repeat polymorphisms. Hum Mol Genet 1993; 2: 43-50.
148. Sherlock J, Halder A, Tutschek B, Delhanty J, Rodeck C, Adinolfi M. Prenatal detection of fetal aneuploidies using transcervical samples. J Med Genet 1997; 34: 302-305.